Innovative 'Cellular Bridges' Offer Hope for Spinal Cord Injury Repair
Recent groundbreaking research highlights a novel approach to spinal cord injury (SCI) treatment by harnessing the regenerative potential of pericytes—tiny cells within the body's blood vessels. Scientists have discovered that introducing a specific growth factor, PDGF-BB, to the injury site prompts pericytes to transform, forming 'cellular bridges' that facilitate nerve regeneration. This process leads to the growth of new axons, the nerve fibers responsible for transmitting signals, which can result in restored movement and reduced pain in animal models.
In experiments with adult mice, a single injection of PDGF-BB at the injury site after seven days initiated significant axon regrowth and functional recovery, including improved hind limb coordination and decreased sensitivity to stimuli. These structural changes were associated with the formation of pericyte-derived bridges across the lesion, enabling nerve fibers to bypass damaged tissues.
Further studies revealed that pericytes respond to PDGF-BB by altering their shape and secreting molecules like fibronectin that promote tissue repair. Culturing mouse neurons on human pericytes exposed to PDGF-BB demonstrated similar growth-promoting effects, indicating potential for translational applications.
Importantly, PDGF-BB treatment also appeared to lessen inflammation and preserve the fundamental features of pericytes, avoiding conversion into harmful cell types. This comprehensive regeneration approach suggests that restoring blood vessel integrity and nerve pathways simultaneously is crucial for effective SCI recovery.
The findings open new pathways for therapeutic strategies, combining vascular and neural regeneration methods. Future research aims to optimize treatment timing, dosage, and delivery systems, moving closer to clinical applications that could significantly improve outcomes for individuals with spinal cord injuries.
Source: https://medicalxpress.com/news/2025-04-cellular-bridges-spinal-cord-injury.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
New Experimental Drug Targets Body's Circadian Clock to Combat Glioblastoma
A groundbreaking compound, SHP1705, targets the circadian clock proteins hijacked by glioblastoma stem cells, offering hope for improved treatments of this aggressive brain cancer.
Social, Cultural, and Economic Factors Influence Risk of Receiving Unsafe Medication
A national study reveals that social, cultural, and economic disparities significantly increase the risk of receiving unsafe or inappropriate medication, highlighting the need for targeted healthcare interventions.
Emerging Role of Weight-Loss Medications Post-Bariatric Surgery in Reducing Heart Disease Risk
New research suggests that weight-loss medications like semaglutide and liraglutide may reduce cardiovascular risk in patients post-bariatric surgery, especially those not achieving optimal weight or diabetes control.